Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

New Larger Volume Extraction System Increases Productivity and Sensitivity

By BiotechDaily International staff writers
Posted on 30 Jun 2014
ISOLUTE SLE+ One Milliliter Supported Liquid Extraction
One Milliliter Supported Liquid Extraction (Photo courtesy of BIOTAGE AB )
Biotechnology and other life science researchers now have available an extraction system for larger volumes that prepares samples of up to one milliliter for LC-MS/MS (liquid chromatography-mass spectroscopy) or GC-MS (gas chromatography-mass spectroscopy) analysis.

The Biotage (Uppsala, Sweden) ISOLUTE SLE+ One Milliliter Supported Liquid Extraction 48-well plate system enables the extraction of larger sample volumes (one milliliter total load volume) than is presently possible in the standard microplate format.

The new format tubes are packed with ISOLUTE SLE+ material, with each well containing sufficient ISOLUTE SLE+ material to efficiently extract one milliliter of aqueous sample. This is an alternative to the existing 96-well formats, which have a maximum capacity of 400 microliters. Larger sample volumes enable the researcher to generate higher sensitivity, higher throughput, and lower detection limits.

The ISOLUTE SLE+ plate is arranged in a six by eight array; with 48 samples being processed per plate. A new compatible 48-well collection plate is also available with a five milliliter capacity so that the entire elution solvent volume can be collected with no need to swap collection vessels.

The plates can be processed using microplate compatible positive pressure manifolds such as the Biotage Pressure+ 96, vacuum manifolds such as the Biotage VacMaster 96, and most automated liquid handling systems.

ISOLUTE SLE+ plates are ideal for the extraction of small molecule drugs, metabolites, and endogenous biomarkers from biological fluid samples prior to analytical techniques such as LC-MS/MS and GC-MS.

Related Links:

Biotage 




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?


WATERS CORPORATION

Channels

Genomics/Proteomics

view channel
Image: Exosomes loaded with catalase (shown in red) efficiently interact with neurons (shown in black) to protect them from the effects of Parkinson\'s disease (Photo courtesy of Dr. Elena Batrakova, University of North Carolina).

Exome Delivery of the Anti-Oxidant Catalase Reduces Parkinson's Disease Symptoms in Mouse Model

The exosome delivery of the antioxidant enzyme catalase was shown to dramatically reduce symptoms of Parkinson's disease (PD) in a mouse model. Exosomes are cell-derived vesicles that are present in... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

27 May 2015 - 28 May 2015
02 Jun 2015 - 03 Jun 2015
15 Jun 2015 - 18 Jun 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.